Literature DB >> 9667823

Arboviral infections of the central nervous system--United States, 1996-1997.

.   

Abstract

Arboviruses include mosquitoborne and tickborne agents that persist in nature in complex cycles involving birds or mammals, including humans. Arboviral infection can cause fever, headache, meningitis, encephalitis, and sometimes death. During 1996-1997, health departments in 19 states reported to CDC 286 confirmed or probable cases (eight fatal) of arboviral encephalitis in humans (132 cases in 1996 and 154 provisionally in 1997). Surveillance programs in 18 states detected enzootic arboviral activity in mosquito or sentinel or wild bird populations, and cases of arboviral disease were recognized among horses or emus in 24 states. This report summarizes information about arboviral infection of the central nervous system in the United States during 1996-1997.

Entities:  

Mesh:

Year:  1998        PMID: 9667823

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

1.  The control of mosquito-borne diseases in New York City.

Authors:  J R Miller
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

2.  Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections.

Authors:  H P Hefti; M Frese; H Landis; C Di Paolo; A Aguzzi; O Haller; J Pavlovic
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Assessment of Arbovirus Surveillance 13 Years after Introduction of West Nile Virus, United States.

Authors:  James L Hadler; Dhara Patel; Roger S Nasci; Lyle R Petersen; James M Hughes; Kristy Bradley; Paul Etkind; Lilly Kan; Jeffrey Engel
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

4.  Guillain-Barré syndrome after chikungunya infection.

Authors:  Gaëtan Lebrun; Karim Chadda; Anne-Hélène Reboux; Olivier Martinet; Bernard-Alex Gaüzère
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.